KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Operating Margin: 2011-2024

Historic Operating Margin for Esperion Therapeutics (ESPR) over the last 14 years, with Dec 2024 value amounting to 16.37%.

  • Esperion Therapeutics' Operating Margin rose 1963.00% to -11.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -9.67%, marking a year-over-year decrease of 1524.00%. This contributed to the annual value of 16.37% for FY2024, which is 15009.00% up from last year.
  • According to the latest figures from FY2024, Esperion Therapeutics' Operating Margin is 16.37%, which was up 112.24% from -133.72% recorded in FY2023.
  • Esperion Therapeutics' 5-year Operating Margin high stood at 16.37% for FY2024, and its period low was -289.02% during FY2021.
  • Over the past 3 years, Esperion Therapeutics' median Operating Margin value was -133.72% (recorded in 2023), while the average stood at -118.39%.
  • Per our database at Business Quant, Esperion Therapeutics' Operating Margin plummeted by 23,567bps in 2021 and then skyrocketed by 15,009bps in 2024.
  • Over the past 5 years, Esperion Therapeutics' Operating Margin (Yearly) stood at -53.35% in 2020, then crashed by 23,567bps to -289.02% in 2021, then surged by 5,119bps to -237.83% in 2022, then skyrocketed by 10,411bps to -133.72% in 2023, then skyrocketed by 15,009bps to 16.37% in 2024.